Technology evaluation: EMD-273063, EMD Lexigen.
Copyright policy )Technology evaluation: EMD-273063, EMD Lexigen.
EMD-273063 is an antibody/cytokine fusion protein comprised of a humanized version of the murine anti-GD2 antibody 14.18 coupled to two molecules of IL-2. It is being developed by EMD Lexigen Research Center Corp (a subsidiary of Merck KGaA) and its sister company, EMD Pharmaceuticals Inc, for the potential treatment of neuroblastoma and melanoma, for which it is in preclinical and phase I clinical trials, respectively.
- Canadian Institutes of Health Research Canada
- Institute of Cancer Research Canada
- Institute of Cancer Research United Kingdom
Clinical Trials, Phase I as Topic, Drug Evaluation, Preclinical, Antibodies, Monoclonal, Patents as Topic, Neuroblastoma, Structure-Activity Relationship, Targeted interleukin-2 therapy antiganglioside gd2 antibody severe combined immunodeficiency dependent cellular cytotoxicity human neuroblastoma metastases high-dose interleukin-2 activated killer-cells phase-i trial fusion protein plus interleukin-2, Animals, Humans, Interleukin-2, Melanoma
Clinical Trials, Phase I as Topic, Drug Evaluation, Preclinical, Antibodies, Monoclonal, Patents as Topic, Neuroblastoma, Structure-Activity Relationship, Targeted interleukin-2 therapy antiganglioside gd2 antibody severe combined immunodeficiency dependent cellular cytotoxicity human neuroblastoma metastases high-dose interleukin-2 activated killer-cells phase-i trial fusion protein plus interleukin-2, Animals, Humans, Interleukin-2, Melanoma
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).7 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!